Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Falagas, Matthew E.
and
Rafailidis, Petros I.
2007.
WHEN TO INCLUDE POLYMYXINS IN THE EMPIRICAL ANTIBIOTIC REGIMEN IN CRITICALLY ILL PATIENTS WITH FEVER? A DECISION ANALYSIS APPROACH.
Shock,
Vol. 27,
Issue. 6,
p.
605.
Giamarellou, Helen
and
Kanellakopoulou, Kyriaki
2008.
Current Therapies for Pseudomonas Aeruginosa.
Critical Care Clinics,
Vol. 24,
Issue. 2,
p.
261.
Matthaiou, Dimitrios K.
Michalopoulos, Argyris
Rafailidis, Petros I.
Karageorgopoulos, Drosos E.
Papaioannou, Vassiliki
Ntani, Georgia
Samonis, George
and
Falagas, Matthew E.
2008.
Risk factors associated with the isolation of colistin-resistant Gram-negative bacteria: A matched case-control study.
Critical Care Medicine,
Vol. 36,
Issue. 3,
p.
807.
Falagas, Matthew E
and
Rafailidis, Petros I
2008.
Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives.
Expert Opinion on Investigational Drugs,
Vol. 17,
Issue. 7,
p.
973.
Figueiredo Costa, Silvia
2008.
IMPACT OF ANTIMICROBIAL RESISTANCE ON THE TREATMENT AND OUTCOME OF PATIENTS WITH SEPSIS.
Shock,
Vol. 30,
Issue. 7,
p.
23.
Schwaiger, Karin
Bauer, Johann
and
Hölzel, Christina Susanne
2013.
Selection and Persistence of Antimicrobial-ResistantEscherichia coliIncluding Extended-Spectrum β-Lactamase Producers in Different Poultry Flocks on One Chicken Farm.
Microbial Drug Resistance,
Vol. 19,
Issue. 6,
p.
498.
Jasemi, S.
Douraghi, M.
Adibhesami, H.
Zeraati, H.
Rahbar, M.
Boroumand, M.A.
Aliramezani, A.
Ghourchian, S.
and
Mohammadzadeh, M.
2016.
Trend of extensively drug-resistantAcinetobacter baumanniiand the remaining therapeutic options: a multicenter study in Tehran, Iran over a 3-year period.
Letters in Applied Microbiology,
Vol. 63,
Issue. 6,
p.
466.